ADEDAPO OKUSANYA: Open Payments
NPI 1619932126 · GLENDALE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,534 in 107 payments from 25 companies in 2025. Trend: 2023 $3,197 · 2024 $3,283 · 2025 $2,534
Food & beverage: $2,459Education: $75
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $281 |
| PFIZER INC. | 16 | $268 |
| Gilead Sciences, Inc. | 7 | $262 |
| AstraZeneca Pharmaceuticals LP | 9 | $225 |
| ABBVIE INC. | 10 | $213 |
| Phathom Pharmaceuticals, Inc. | 6 | $186 |
| Novo Nordisk Inc | 7 | $158 |
| Indivior Inc. | 6 | $145 |
| Astellas Pharma US Inc | 3 | $106 |
| Aimmune Therapeutics, Inc. | 4 | $82 |
Products named: CAPLYTA, BREZTRI, VOQUEZNA, NURTEC ODT, SUBLOCADE, Livdelzi, VRAYLAR, Ozempic.
Industry payments across WI — which companies pay providers there.
